- Public Comps
- Colgate-Palmolive (India)
Colgate-Palmolive (India) Valuation Multiples
Discover revenue and EBITDA valuation multiples for Colgate-Palmolive (India) and similar public comparables like Bausch + Lomb, AmorePacific, Yakult Honsha, e.l.f. Beauty and more.
Colgate-Palmolive (India) Overview
About Colgate-Palmolive (India)
Colgate-Palmolive (India) Ltd is a personal care and oral care company. The company operates under a single reportable segment, Personal Care (including Oral Care), which includes soaps, cosmetics, toilet preparations, and other products. The company manufactures oral-care products, such as toothpaste, toothbrushes, whitening products, and mouthwash solutions. Personal care products include body wash, hand soaps, skincare, and hair care. Geographically, the company generates a majority of its revenue within India and the rest from overseas markets.
Founded
1937
HQ

Employees
2.2K
Website
Sectors
Financials (LTM)
EV
$5.6B
Valuation Multiples
Start free trialColgate-Palmolive (India) Financials
Colgate-Palmolive (India) reported last 12-month revenue of $644M and EBITDA of $199M.
In the same LTM period, Colgate-Palmolive (India) generated $447M in gross profit, $199M in EBITDA, and $143M in net income.
Revenue (LTM)
Colgate-Palmolive (India) P&L
In the most recent fiscal year, Colgate-Palmolive (India) reported revenue of $629M and EBITDA of $200M.
Colgate-Palmolive (India) is profitable as of last fiscal year, with gross margin of 63%, EBITDA margin of 32%, and net margin of 22%.
Financial data powered by Morningstar, Inc.
Colgate-Palmolive (India) Stock Performance
Colgate-Palmolive (India) has current market cap of $5.8B, and enterprise value of $5.6B.
Market Cap Evolution
Colgate-Palmolive (India)'s stock price is $21.15.
Colgate-Palmolive (India) share price increased by 0.3% in the last 30 days, and decreased by 12.9% in the last year.
Colgate-Palmolive (India) has an EPS (earnings per share) of $0.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.6B | $5.8B | 0.1% | 0.3% | -4.2% | -12.9% | $0.52 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialColgate-Palmolive (India) Valuation Multiples
Colgate-Palmolive (India) trades at 8.7x EV/Revenue multiple, and 28.1x EV/EBITDA.
EV / Revenue (LTM)
Colgate-Palmolive (India) Financial Valuation Multiples
As of July 19, 2026, Colgate-Palmolive (India) has market cap of $5.8B and EV of $5.6B.
Colgate-Palmolive (India) has a P/E ratio of 40.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Colgate-Palmolive (India) Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Colgate-Palmolive (India) Margins & Growth Rates
Colgate-Palmolive (India) grew revenue by 8% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, Colgate-Palmolive (India) reported gross margin of 63%, EBITDA margin of 32%, and net margin of 22%.
Colgate-Palmolive (India) Margins
Colgate-Palmolive (India) Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive (India) Operational KPIs
Colgate-Palmolive (India)'s revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Colgate-Palmolive (India)'s Rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Colgate-Palmolive (India)'s Rule of X is 48% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive (India) Competitors
Colgate-Palmolive (India) competitors include Bausch + Lomb, AmorePacific, Yakult Honsha, e.l.f. Beauty, GSK India, Bayer Perú, Shiseido, Inter Parfums, Giant Biogene and Dabur India.
Most Colgate-Palmolive (India) public comparables operate across Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.1x | 2.0x | 11.8x | 11.0x | |||
| 1.6x | 1.5x | 10.9x | 10.4x | |||
| 1.4x | 1.4x | 7.1x | 9.4x | |||
| 3.0x | 2.9x | 14.8x | 14.3x | |||
| 10.1x | 9.8x | 26.3x | 28.4x | |||
| - | - | - | - | |||
| 1.4x | 1.4x | 13.2x | 12.1x | |||
| 2.6x | 2.6x | 12.8x | 13.3x | |||
This data is available for Pro users. Sign up to see all Colgate-Palmolive (India) competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Colgate-Palmolive (India)
| Who are competitors of Colgate-Palmolive (India)? | Colgate-Palmolive (India) main competitors include Bausch + Lomb, AmorePacific, Yakult Honsha, e.l.f. Beauty, GSK India, Bayer Perú, Shiseido, Inter Parfums, Giant Biogene, Dabur India. |
See public comps similar to Colgate-Palmolive (India)
Lists including Colgate-Palmolive (India)
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




